期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (7)
Background Inhibition of vascular endothelial growth factor receptor (VEGFR) has shown antitumour activity in advanced hepatocellular carcinoma, but f......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (5)
lead to altered infectivity, virulence, and severity. What effect this will have on patients with IBD remains to be seen. A notable additional conside......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (9)
Inflammatory bowel diseases, principally Crohn's disease and ulcerative colitis, are multifactorial chronic conditions. Alterations in gut microbial p......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (3)
Background Diagnostic tools for liver disease can now include estimation of the grade of hepatic steatosis (S0 to S3). Controlled attenuation paramete......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (7)
Background Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of pregnancy, yet its largest trial detected minimal benefit for a ......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (9)
Background White light endoscopy is a pivotal first-line tool for the detection of gastric neoplasms. However, gastric neoplasms can be missed during ......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (9)
Background RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator being developed for the treatment of chronic HBV infection, was foun......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (6)
Findings Of the 6863 publications identified, 70 articles describing 73 randomised controlled trials were included in our analysis. The pooled placebo......
期刊： LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021; 6 (2)
Background Peritoneal recurrence of gastric cancer after curative surgical resection is common and portends a poor prognosis. Early studies suggest th......
